Impact of low hemoglobin on the development of contrast-induced nephropathy: A retrospective cohort study

Xu,Jinzhong; Zhang,Meiling; Ni,Yinghua; Shi,Jiana; Gao,Ranran; Wang,Fan; Dong,Zhibing; Zhu,Lingjun; Liu,Yanlong; Xu,Huimin

doi:10.3892/etm.2016.3416

Impact of low hemoglobin on the development of contrast-induced nephropathy: A retrospective cohort study

Authors:
- Jinzhong Xu
- Meiling Zhang
- Yinghua Ni
- Jiana Shi
- Ranran Gao
- Fan Wang
- Zhibing Dong
- Lingjun Zhu
- Yanlong Liu
- Huimin Xu
View Affiliations

Affiliations: Department of Clinical Pharmacy, The Affiliated Wenling Hospital of Wenzhou Medical University, Wenling, Zhejiang 317500, P.R. China, Department of Pharmacy, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, P.R. China, Department of Clinical Pharmacy, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, P.R. China, Department of Pharmacy, Zhejiang Province People's Hospital, Hangzhou, Zhejiang 31014, P.R. China, Department of Cardiovascular Medicine, The Affiliated Wenling Hospital of Wenzhou Medical University, Wenling, Zhejiang 317500, P.R. China, Beijing Hui‑Long‑Guan Hospital, Peking University, Beijing 100096, P.R. China, Department of Cardiovascular Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China, College of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, P.R. China, Department of Clinical Pharmacy, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China
Published online on: June 2, 2016 https://doi.org/10.3892/etm.2016.3416
Pages: 603-610
Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

An increase in the use of iodinated contrast media, such as iohexol, iodixanol, iopamidol and iopromide, occasionally causes contrast-induced nephropathy (CIN) in patients undergoing coronary angiography (CAG) and/or percutaneous coronary intervention (PCI). The present study aimed to assess the effects of low levels of hemoglobin on the development of CIN in patients with normal renal function following CAG/PCI. A total of 841 consecutive patients undergoing CAG/PCI were divided into two groups: Patients with low levels of hemoglobin (male, <120 g/l; female, <110 g/l; n=156) and normal levels of hemoglobin (male, 120‑160 g/l; female, 110‑150 g/l; n=685). Multiple logistic regression analysis was performed to identify risk factors for CIN, which developed in 14.7% of patients with low levels of hemoglobin (relative risk, 3.07) and 5% of patients with normal levels of hemoglobin (P<0.01). Independent risk factors for developing CIN in patients with low levels of hemoglobin were a contrast media volume ≥200 ml, diuretic usage, low levels of hemoglobin and diabetes mellitus. For the patients with normal hemoglobin levels, the independent risk factors for developing CIN were a contrast media volume ≥200 ml and diuretic usage. The change in serum creatinine in patients with low levels of hemoglobin was significantly greater compared with patients with normal levels of hemoglobin (7.35±22.60 vs. 1.40±12.00; P<0.01). A similar incidence of developing CIN was observed when patients were administered each type of contrast media: Iohexol, iodixanol, iopamidol and iopromide. The optimal cut‑off point at which the serum hemoglobin concentration resulted in a high probability of developing CIN was determined as 111.5 g/l in females and 115.5 g/l in males. In conclusion, low levels of hemoglobin were observed to be an independent risk factor for developing CIN. Patients with reduced hemoglobin levels should, therefore, be closely monitored prior to, and during, the administration of iodinated contrast media.

View Figures

View References

1	Parfrey P, Griffiths S, Barrett B, Paul MD, Genge M, Withers J, Farid N and McManamon PJ: Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency or both: A prospective controlled study. N Engl J Med. 320:143–149. 1989. View Article : Google Scholar : PubMed/NCBI
2	Gandhi S, Mosleh W, Abdel-Qadir H and Farkouh ME: Statins and contrast-induced acute kidney injury with coronary angiography. Am J Med. 127:987–1000. 2014. View Article : Google Scholar : PubMed/NCBI
3	Chertow GM, Christiansen CL, Cleary PD, Munro C and Lazarus JM: Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med. 155:1505–1511. 1995. View Article : Google Scholar : PubMed/NCBI
4	Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, et al: Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 105:2259–2264. 2002. View Article : Google Scholar : PubMed/NCBI
5	Palli E, Makris D, Papanikolaou J, Garoufalis G and Zakynthinos E: Contrast-induced nephropathy in aged critically ill patients. Oxid Med Cell Longev. 2014:7564692014. View Article : Google Scholar : PubMed/NCBI
6	Kwasa EA, Vinayak S and Armstrong R: The role of inflammation in contrast-induced nephropathy. Br J Radiol. 87:201307382014. View Article : Google Scholar : PubMed/NCBI
7	Pucelikova T, Dangas G and Mehran R: Contrast-induced nephropathy. Catheter Cardiovasc Interv. 71:62–72. 2008. View Article : Google Scholar : PubMed/NCBI
8	Toprak O, Cirit M, Yesil M, Bayata S, Tanrisev M, Varol U, Ersoy R and Esi E: Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. Nephrol Dial Transplant. 22:819–826. 2007. View Article : Google Scholar : PubMed/NCBI
9	Mehran R and Nikolsky E: Contrast-induced nephropathy: Definition, epidemiology, and patients at risk. Kidney Int Suppl. 69:S11–S15. 2006. View Article : Google Scholar
10	Lee J, Cho JY, Lee HJ, Jeong YY, Kim CK, Park BK, Sung DJ, Kang BC, Jung SI, Lee EJ, et al: Korean Society of Urogenital Radiology (KSUR); Korean Society of Radiology: Contrast-induced nephropathy in patients undergoing intravenous contrast-enhanced computed tomography in Korea: A multi-institutional study in 101487 patients. Korean J Radiol. 15:456–463. 2014. View Article : Google Scholar : PubMed/NCBI
11	Nikolsky E, Mehran R, Lasic Z, Mintz GS, Lansky AJ, Na Y, Pocock S, Negoita M, Moussa I, Stone GW, et al: Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int. 67:706–713. 2005. View Article : Google Scholar : PubMed/NCBI
12	Celsing F, Svedenhag J, Pihlstedt P and Ekblom B: Effects of anaemia and stepwise-induced polycythaemia on maximal aerobic power in individuals with high and low haemoglobin concentrations. Acta Physiol Scand. 129:47–54. 1987. View Article : Google Scholar : PubMed/NCBI
13	Kim SJ, Salem MR, Joseph NJ, Madayag MA, Cavallino RP and Crystal GJ: Contrast media adversely affect oxyhemoglobin dissociation. Anesth Analg. 71:73–76. 1990. View Article : Google Scholar : PubMed/NCBI
14	Heyman SN, Evans RG, Rosen S and Rosenberger C: Cellular adaptive changes in AKI: Mitigating renal hypoxic injury. Nephrol Dial Transplant. 27:1721–1728. 2012. View Article : Google Scholar : PubMed/NCBI
15	Cigarroa RG, Lange RA, Williams RH and Hillis LD: Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 86:649–652. 1989. View Article : Google Scholar : PubMed/NCBI
16	Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, et al: ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 33:2569–619. 2012. View Article : Google Scholar : PubMed/NCBI
17	Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, et al: ESC Committee for Practice Guidelines: ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 32:2999–3054. 2011. View Article : Google Scholar : PubMed/NCBI
18	Liu LS: Writing Group of 2010 Chinese Guidelines for the Management of Hypertension: 2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 39:579–615. 2011.(In Chinese). PubMed/NCBI
19	Chinese Diabetes Society: 2010 Chinese Guidelines for the Management of Diabetes. Zhonghua Xin Xue Guan Bing Za Zhi. 20:S1–S36. 2012.(In Chinese).
20	Ruilope LM, Salvetti A, Jamerson K, Hansson L, Warnold I, Wedel H and Zanchetti A: Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol. 12:218–225. 2001.PubMed/NCBI
21	Guo J, Zheng C, Xiao Q, Gong S, Zhao Q, Wang L, He J, Yang W, Shi X, Sun X and Liu J: Impact of anaemia on lung function and exercise capacity in patients with stable severe chronic obstructive pulmonary disease. BMJ Open. 5:e0082952015. View Article : Google Scholar : PubMed/NCBI
22	Chinese Society of Cardiology; Editorial Committee of Chinese Journal of Cardiology: Chinese expert consensus on the clinical application of iodinated contrast media in cardiovascular diseases. Zhonghua Xin Xue Guan Bing Za Zhi. 41:94–98. 2013.(In Chinese). PubMed/NCBI
23	Rich MW and Crecelius CA: Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med. 150:1237–1242. 1990. View Article : Google Scholar : PubMed/NCBI
24	Kini AS, Mitre CA, Kim M, Kamran M, Reich D and Sharma SK: A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: Effect of selective dopamine receptor agonist fenoldopam. Catheter Cardiovasc Interv. 55:169–173. 2002. View Article : Google Scholar : PubMed/NCBI
25	Solomon R: The role of osmolality in the incidence of contrast-induced nephropathy: A systematic review of angiographic contrast media in high risk patients. Kidney Int. 68:2256–2263. 2005. View Article : Google Scholar : PubMed/NCBI
26	Barrett BJ and Carlisle EJ: Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology. 188:171–178. 1993. View Article : Google Scholar : PubMed/NCBI
27	Nozue T, Michishita I, Iwaki T, Mizuguchi I and Miura M: Contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy developing after elective percutaneous coronary intervention. J Cardiol. 54:214–220. 2009. View Article : Google Scholar : PubMed/NCBI
28	Goldenberg I and Matetzky S: Nephropathy induced by contrast media: Pathogenesis, risk factors and preventive strategies. CMAJ. 172:1461–1471. 2005. View Article : Google Scholar : PubMed/NCBI
29	Chinese society of cardiology, Editorial committee of Chinese journal of cardiology: Chinese expert consensus on the clinical application of iodinated contrast media in cardiovascular diseases. Chinese Journal of Cardiology. 41:94–98. 2013.PubMed/NCBI
30	Alamartine E, Phayphet M, Thibaudin D, Barral FG and Veyret C: Contrast medium-induced acute renal failure and cholesterol embolism after radiological procedures: Incidence, risk factors, and compliance with recommendations. Eur J Intern Med. 14:426–431. 2003. View Article : Google Scholar : PubMed/NCBI
31	Ho KM and Power BM: Benefits and risks of furosemide in acute kidney injury. Anaesthesia. 65:283–293. 2010. View Article : Google Scholar : PubMed/NCBI
32	Gu GQ, Lu R, Cui W, Liu F, Zhang Y, Yang XH, Chen XF and Jia WM: Low-dose furosemide administered with adequate hydration reduces contrast-induced nephropathy in patients undergoing coronary angiography. Cardiology. 125:69–73. 2013. View Article : Google Scholar : PubMed/NCBI
33	Toprak O and Cirit M: Risk factors for contrast-induced nephropathy. Kidney Blood Press Res. 29:84–93. 2006. View Article : Google Scholar : PubMed/NCBI
34	Toprak O, Cirit M, Yesil M, Byrne DW, Postaci N, Bayata S, Majchrzak KM and Esi E: Metabolic syndrome as a risk factor for contrast-induced nephropathy in non-diabetic elderly patients with renal impairment. Kidney Blood Press Res. 29:2–9. 2006. View Article : Google Scholar : PubMed/NCBI
35	Liu Y, Tan N, Zhou YL, He PC, Luo JF and Chen JY: The contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy after primary percutaneous coronary intervention. Int Urol Nephrol. 44:221–229. 2012. View Article : Google Scholar : PubMed/NCBI
36	Macciò A, Madeddu C, Gramignano G, Mulas C, Tanca L, Cherchi MC, Floris C, Omoto I, Barracca A and Ganz T: The role of inflammation, iron, and nutritional status in cancer-related anemia: Results of a large, prospective, observational study. Haematologica. 100:124–132. 2015. View Article : Google Scholar : PubMed/NCBI
37	Weiss G and Goodnough LT: Anemia of chronic disease. N Engl J Med. 352:1011–1023. 2005. View Article : Google Scholar : PubMed/NCBI
38	Waters JS, O'Brien ME and Ashley S: Management of anemia in patients receiving chemotherapy. J Clin Oncol. 20:601–603. 2002.PubMed/NCBI
39	Hsu CY, McCulloch CE and Curhan GC: Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: Results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol. 13:504–510. 2002.PubMed/NCBI
40	Nurko S: Anemia in chronic kidney disease: Causes, diagnosis, treatment. Cleve Clin J Med. 73:289–297. 2006. View Article : Google Scholar : PubMed/NCBI
41	Astor BC, Coresh J, Heiss G, Pettitt D and Sarnak MJ: Kidney function and anemia as risk factors for coronary heart disease and mortality: The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 151:492–500. 2006. View Article : Google Scholar : PubMed/NCBI
42	Shah AD, Nicholas O, Timmis AD, Feder G, Abrams KR, Chen R, Hingorani AD and Hemingway H: Threshold haemoglobin levels and the prognosis of stable coronary disease: Two new cohorts and a systematic review and meta-analysis. PLoS Med. 8:e10004392011. View Article : Google Scholar : PubMed/NCBI
43	Carson JL, Noveck H, Berlin JA and Gould SA: Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion. 42:812–818. 2002. View Article : Google Scholar : PubMed/NCBI
44	Barbarova I, Klempfner R, Rapoport A, Wasserstrum Y, Goren I, Kats A and Segal G: Avoidance of Blood Transfusion to Patients Suffering From Myocardial Injury and Severe Anemia Is Associated With Increased Long-Term Mortality: A Retrospective Cohort Analysis. Medicine (Baltimore). 29:e16352015. View Article : Google Scholar
45	Klein MJ, Carter TI, Smith MC, Wong J and Sugiyama G: Prophylactic hypothermia and neuromuscular blockade to limit myocardial oxygen demand in a critically anemic Jehovah's Witness after emergency surgery. J Surg Case Rep. 12:rju1352014. View Article : Google Scholar
46	McCullough PA and Sandberg KR: Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med. 4(Suppl 5): S3–S9. 2003.
47	World Health Organization: Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. WHO. (Geneva). 1–6. 2011.